Effects of Salt on Serum Osmolarity and Hemodynamics Parameters
Effects of Salt and The Amount of Water Consumption Simultaneously On Serum Osmolarity and Their Effects on Hemodynamic Parameters and Inflammation
1 other identifier
interventional
10
1 country
1
Brief Summary
Diets containing excessive salt (\>12 g/day) have negative effects on kidney and cardiovascular system. Considering this known fact, the investigators aimed to study if the amount of the water taken with excessive salt had any part on these negative effects by testing the blood pressure, serum osmolality, endothelial functions, cardiac function, inflammatory parameters and sympathetic nervous system. Excessive dietary salt raises the serum osmolality, which triggers the protection mechanisms of the body. The first mechanism is the secretion of vasopressin from posterior pituitary and the second one is the polyol mediated aldose reductase enzyme activation in renal tubules. In the beginning, water and a little amount of salt is reabsorbed from the kidneys for keeping the serum osmolality in normal ranges by the elevation of vasopressin. Besides the high levels of vasopressin for long durations may have a role in both developments of hypertension and the progression/development of chronic kidney disease. Polyol mediated aldose reductase enzyme turns glucose into sorbitol, which is turned to fructose by sorbitol dehydrogenase activity. Fructose is degraded by fructokinase activity into toxic substances. With this pathway, the acute energy need is satisfied, yet uric acid, local oxidative stress, and inflammatory mediators rise while nitric oxide levels decreasing. These facts are independent risk factors for both kidney disease progression and hypertension. In addition, excessive salt intake may elevate the transforming growth factor beta-1 (TGF-B1) levels, which activates the sympathetic system, inflammation, and endothelial dysfunction. According to these data, the investigators speculate that if they increase the amount of water intake while eating the high salt diet they may decrease the toxic effect of salt with less increase in serum osmolarity. To test this hypothesis, by regulating the salt and water amount in healthy people's diets, the investigators aimed to evaluate the following these parameters; biochemical parameters that could affect the blood and urine osmolality, blood pressure, vascular endothelial functions with the non-invasive flow-mediated dilatation technique and arterial stiffness, systolic and diastolic functions of the heart by transthoracic echocardiography. In addition, it was planned to evaluate the hormonal effects of arginine vasopressin, a long peptide with 39 amino acids, which is longer and easier to measure than vasopressin levels in serum by measuring the pituitary hormone-derived copeptin. Although, decreasing the salt intake is the first step of the treatment in hypertension, and kidney diseases, the compliance rate to less sodium intake is very low (\<20%). The investigators aim is to evaluate the effects of water, which is taken acutely with the excessive salt intake on cardiovascular system and kidney. The findings of the study will important for public health. If the investigators prove their hypothesis, they may recommend increasing high water intake before feeling thirst of which may contribute to decreasing the prevalence of hypertension and kidney disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started Sep 2017
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2017
CompletedFirst Submitted
Initial submission to the registry
September 28, 2017
CompletedFirst Posted
Study publicly available on registry
October 19, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2017
CompletedFebruary 9, 2018
September 1, 2017
2 months
September 28, 2017
February 8, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline systolic and diastolic blood pressure
Systolic and diastolic blood pressures are measured with an aneroid sphygmomanometer. Unit of measurement is mmHg.
Baseline time 0, Hour 1, Hour 2, Hour 3, Hour 4
Secondary Outcomes (5)
Serum osmolarity increase
Baseline time 0, Hour 1, Hour 2, Hour 3, Hour 4
Change from baseline blood copeptin levels
Baseline time 0, Hour 1, Hour 2, Hour 3, Hour 4
Change from baseline augmentation index
Baseline time 0, Hour 4
Change from baseline pulse wave velocity
Baseline time 0, Hour 4
Change from baseline flow mediated dilation
Baseline time 0, Hour 4
Study Arms (2)
Control group
NO INTERVENTIONDrink 200 ml soup with no added salt
High salt (NaCl) intake
EXPERIMENTALGroup 2: Drink 200 ml soup with 3 g added salt Group 3: Drink 200 ml soup with 3 g added salt plus 500 ml water Group 4: Drink 200 ml soup with 3 g added salt plus 750 ml water
Interventions
Participants are asked to consume two high sodium-containing soups while monitoring their serum osmolarity levels
Eligibility Criteria
You may qualify if:
- Healthy, no smoker, no obese \>30 BMI, no drug use in the previous month
You may not qualify if:
- Any systemic disease, no past history of any cardiovascular disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Koç Universitylead
Study Sites (1)
Koc University Hospital
Istanbul, 34010, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mehmet Kanbay, MD
Koc University Sch. Med. Dept. Internal Med. Nephrology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 28, 2017
First Posted
October 19, 2017
Study Start
September 1, 2017
Primary Completion
November 1, 2017
Study Completion
November 30, 2017
Last Updated
February 9, 2018
Record last verified: 2017-09